Indian children aged 12 or older will become eligible for Covid vaccinations from October 2021. Reuters reported that the plan will be taken into consideration after the drugmaker Cadila Healthcare launches its ZyCoV-D product. ZyCoV-D is the world’s first DNA-based Covid vaccine and it was reported that the vaccine won emergency authorization from Indian regulators last month.
The company named Zydus Cadila will produce 10 million doses a month, starting from the month of October. However, the health ministry did not immediately respond to a request for comment. The sources sought anonymity because they were not authorized to talk to the media.
The ZyCoV-D vaccine is the only approved vaccine for children in India and it has given a total of 825.9 million doses to adults among its population of nearly 1.4 billion.
Meanwhile, India is all set to get its first Johnson & Johnson Covid-19 vaccine doses soon. The vaccine got its approval from WHO and a total of 65 countries approved the vaccine. It could receive as many as 43.5 million doses of the single-shot vaccine in October, said the source – a big step toward helping India meet its target of producing more than 300 million doses a month.